Jin, X.; Oh, J.; Cho, J.-Y.; Lee, S.; Rhee, S.-j.
Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease. Antibiotics 2020, 9, 784.
https://doi.org/10.3390/antibiotics9110784
AMA Style
Jin X, Oh J, Cho J-Y, Lee S, Rhee S-j.
Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease. Antibiotics. 2020; 9(11):784.
https://doi.org/10.3390/antibiotics9110784
Chicago/Turabian Style
Jin, Xuanyou, Jaeseong Oh, Joo-Youn Cho, SeungHwan Lee, and Su-jin Rhee.
2020. "Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease" Antibiotics 9, no. 11: 784.
https://doi.org/10.3390/antibiotics9110784
APA Style
Jin, X., Oh, J., Cho, J. -Y., Lee, S., & Rhee, S. -j.
(2020). Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease. Antibiotics, 9(11), 784.
https://doi.org/10.3390/antibiotics9110784